Computed from every Form D fund launch on EDGAR since late 2024, not sampled. Amounts are the stated offering size; indefinite offerings are excluded.
| Filed | Form | Sold | Investors | Change |
|---|---|---|---|---|
| 2025-09-29 | D | $0 | 0 | |
| 2026-09-29 | D/A | $113.9M | 27 | +$113.9M |
Amount sold and investor count as restated on each of the issuer's Form D filings. A rise since the previous filing is capital closed in between.
Earlier and related filings by the same issuer and sponsor.
Sold rose to $NaN (+$113.9M, +27 investors) in 365 days since the previous filing.
| Stephen Squinto | Executive Officer |
| N/A 270 Healthcare Growth Fund I GP LLC | Director |
| Gaurav Gupta | Executive Officer |
| Anya Schiess | Executive Officer |
| Samantha Beattie | Executive Officer |
| Patrick McGoldrick | Executive Officer |
| Joseph Siletto | Executive Officer |
[email protected] · observed Work emails for the people on the filing, where the firm publishes or patterns them, labelled by confidence — subscribers
Signed by Samantha Beattie, Executive Director of the Investment Manager.
Placement agents / sales compensation: J.P. Morgan Institutional Investments Inc.; J.P. Morgan Securities LLC
Relevant to: Fund administrator, Fund audit & tax, Fund-formation counsel.
The issuer's phone number and address from the filing are shown to subscribers. See plans.
